Risks of noncardiac surgery early after percutaneous coronary intervention

被引:16
|
作者
Smilowitz, Nathaniel R. [1 ,2 ]
Lorin, Jeffrey [1 ,2 ]
Berger, Jeffrey S. [1 ,3 ]
机构
[1] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA
[2] Vet Affairs New York Harbor Hlth Care Syst, Dept Med, Div Cardiol, New York, NY USA
[3] NYU, Sch Med, Dept Surg, New York, NY USA
基金
美国国家卫生研究院;
关键词
DRUG-ELUTING STENTS; ADVERSE CARDIAC EVENTS; PERIOPERATIVE MANAGEMENT; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CARDIOVASCULAR RISK; 30-DAY MORTALITY; TROPONIN LEVELS; ASSOCIATION; REVASCULARIZATION;
D O I
10.1016/j.ahj.2019.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prior registry data suggest that 4%-20% of patients require noncardiac surgery (NCS) within 2 years of percutaneous coronary intervention (PCI). Contemporary data on NCS after PCI in the United States among women and men are limited. We determined the rate of early hospital readmission for NCS and associated outcomes in a large cohort of patients who underwent PCI in the United States. Methods Adults undergoing PCI between January 1 and June 30, 2014, were identified from the Nationwide Readmission Database. Patients readmitted for NCS within 6 months of PCI were identified. Outcomes of interest were inhospital death, myocardial infarction (MI), and bleeding defined by international Classification of Diseases, Ninth Revision, codes. Results Among 221,379 patients who underwent PCI and survived to hospital discharge, 3.5% (n = 7,696) were readmitted for NCS within 6 months post-PCI, and 41% of these hospitalizations were elective. Early NCS was complicated by MI in 4.7% of cases, and 21% of perioperative MIs were fatal. Bleeding was recorded in 32.0% of patients. All-cause mortality occurred in 4.4% of patients (n = 339) readmitted for surgery. The risk of death or MI was greatest when NCS was performed within the first month after PCI. Conclusions Despite clear guidelines to avoid surgery early after PCI, NCS was performed in 1 of every 29 patients with recent PCI, corresponding to as many as similar to 30,000 patients each year nationwide. Surgical mortality and perioperative MI were high in this setting. Strategies to minimize perioperative thrombotic and bleeding risks during readmission for NCS after PCI are necessary.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [31] Anesthetic Agents and Cardiovascular Outcomes of Noncardiac Surgery after Coronary Stent Insertion
    Yoon, Hyun-Kyu
    Jun, Kwanghoon
    Park, Sun-Kyung
    Ji, Sang-Hwan
    Jang, Young-Eun
    Yoo, Seokha
    Kim, Jin-Tae
    Kim, Won Ho
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [32] Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention
    Ndrepepa, Gjin
    Guerra, Elena
    Schulz, Stefanie
    Fusaro, Massimiliano
    Cassese, Salvatore
    Kastrati, Adnan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (01) : 35 - 42
  • [33] Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency
    Yan, Liqiu
    Li, Peiyao
    Wang, Yabin
    Han, Dong
    Li, Sulei
    Zhang, Jibin
    Jiang, Min
    Fan, Li
    Han, Yaling
    Cao, Feng
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 : 606 - 615
  • [34] Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks
    Yang, Seokhun
    Kang, Jeehoon
    Park, Kyung Woo
    Hur, Seung-Ho
    Lee, Nam Ho
    Hwang, Doyeon
    Yang, Han-Mo
    Ahn, Hyo-Suk
    Cha, Kwang Soo
    Jo, Sang-Ho
    Ryu, Jae Kean
    Suh, Il-Woo
    Choi, Hyun-Hee
    Woo, Seong-Ill
    Han, Jung-Kyu
    Shin, Eun-Seok
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (16) : 1565 - 1578
  • [35] Coronary Artery Bypass Graft Surgery After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction
    Bagheri, Jamshid
    Jameie, Mana
    Saryazdi, Zahra Dehghani
    Jalali, Arash
    Rezaee, Malihe
    Pashang, Mina
    Aein, Afsaneh
    Hosseini, Kaveh
    Tafti, Seyed Hossein Ahmadi
    Bagheri, Amin
    HEART LUNG AND CIRCULATION, 2023, 32 (10): : 1257 - 1268
  • [36] Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study
    Wickbom, Anders
    Fengsrud, Espen
    Alfredsson, Joakim
    Engdahl, Johan
    Kalm, Torbjoern
    Ahlsson, Anders
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2024, 58 (01)
  • [37] Functional Status and Search for Meaning After Percutaneous Coronary Intervention
    Skaggs, Brenda G.
    Yates, Bernice C.
    WESTERN JOURNAL OF NURSING RESEARCH, 2016, 38 (02) : 248 - 261
  • [38] Ticagrelor With or Without Aspirin After Complex Percutaneous Coronary Intervention
    Dangas, George
    Baber, Usman
    Sharma, Samin
    Giustino, Gennaro
    Mehta, Shamir
    Cohen, David J.
    Angiolillo, Dominick J.
    Sartori, Samantha
    Chandiramani, Rishi
    Briguori, Carlo
    Dudek, Dariusz
    Escaned, Javier
    Huber, Kurt
    Collier, Timothy
    Kornowski, Ran
    Kunadian, Vijay
    Kaul, Upendra
    Oldroyd, Keith
    Sardella, Gennaro
    Shlofmitz, Richard
    Witzenbichler, Bernhard
    Han Ya-Ling
    Pocock, Stuart
    Gibson, C. Michael
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (19) : 2414 - 2424
  • [39] Effects of Curcuminoids on Myocardial Injury After Percutaneous Coronary Intervention
    Phrommintikul, Arintaya
    Chanchai, Rattanachai
    Wongcharoen, Wanwarang
    JOURNAL OF MEDICINAL FOOD, 2019, 22 (07) : 680 - 684
  • [40] Outcomes of Renal Transplant Recipients after Percutaneous Coronary Intervention
    Nakao, Masashi
    Yamaguchi, Junichi
    Satomi, Natsuko
    Ebihara, Suguru
    Tanaka, Kazuki
    Otsuki, Hisao
    Inagaki, Yusuke
    Jujo, Kentaro
    Arashi, Hiroyuki
    Hagiwara, Nobuhisa
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (09): : 1305 - 1311